12th Academic Annual Conference of the Oncology External Therapy Committee of WFCMS Kicks Off in Shenzhen

On December 6-7, 2025, the "12th Annual Academic Conference of the World Federation of Chinese Medicine Societies (WFCMS) Specialized Committee on External Treatment Methods for Cancer and the First Intelligent Integration and Innovation Exchange Conference on Traditional Chinese Medicine (TCM) Oncology, and the 2nd Annual Academic Conference of the TCM Oncology Branch of the Beijing Integrated Medicine Association" will grandly open in Shenzhen. This grand event is hosted by the WFCMS Specialized Committee on External Treatment Methods for Cancer, the Beijing Integrated Medicine Association, the TCM Oncology Branch of the Beijing Integrated Medicine Association, and the Oncology Cooperation Committee of the Beijing Research Association of TCM for Difficult Diseases, with the support of the Shenzhen Senior TCM Practitioners Association and strong backing from Xiangyu Medical Co., Ltd. The conference, themed “Inheritance and Innovation, Integration and Empowerment, Leading Development,” focuses on the inheritance and optimization of TCM oncology, the cross-disciplinary integration of intelligent technologies with TCM cancer diagnosis and treatment, and clinical practices in integrated TCM-Western medicine cancer prevention and treatment. It systematically showcases the latest research progress and development trends in the field of TCM oncology. Professor Zhu Qingwen, Vice Chairman and Secretary General of the WFCMS Specialized Committee on External Treatment Methods for Cancer, presided over the opening ceremony, with nearly 200 experts and scholars attending in person and over 2 million online views, creating a strong academic atmosphere and generating enthusiastic industry response.

Opening Ceremony Host: Professor Zhu Qingwen

Ms. Xu Chunbo, Deputy Secretary-General of the World Federation of Chinese Medicine Societies (WFCMS), on behalf of the WFCMS Secretariat, extended a warm welcome to the leaders and guests attending this conference. She pointed out: "Branches are an important part of the WFCMS and also a key platform for promoting academic development and strengthening international exchanges. Since its leadership change 12 years ago, under the guidance of President Li Zhong and the Board of Directors, the WFCMS Special Committee on External Treatment Methods for Cancer has remained true to its original mission and forged ahead. Focusing on clinical research innovation, the development of appropriate external treatment technologies for cancer, improving grassroots healthcare standards, and cultivating specialized talent, it has united experts and scholars from China and abroad. The committee has actively organized academic activities and launched the 'Hundred People, Hundred Lessons' project, providing efficient and high-quality Chinese treatment solutions for cancer patients worldwide. It has made outstanding contributions to promoting the inheritance and innovation of Traditional Chinese Medicine (TCM) and advancing the high-quality international development of TCM!"

Speech by Ms. Xu Chunbo, Deputy Secretary General of the World Federation of Chinese Medicine Societies

Huang Zemin, Honorary President of the former Beijing Integrated Medicine Association, stated in his speech: "This academic annual conference closely follows the overall development plan of the country and has specially established the 'First Digital Intelligence Traditional Chinese Medicine Oncology Fusion Innovation Exchange Conference.' This not only deepens the concept and practice of integrated medicine but also represents an important expansion for the future-oriented fusion and innovation of traditional Chinese medicine. We look forward to opening up a promising new path for the precise prevention and treatment, efficacy evaluation, and comprehensive management of tumors by integrating modern digital intelligence technologies such as artificial intelligence and big data with the holistic and dialectical perspectives of traditional Chinese medicine."

Speech by Mr. Huang Zemin, Honorary President of the Former Beijing Integrated Medicine Association

Mr. Liu Guangyi, Standing Vice President of the Beijing Research Association of Traditional Chinese Medicine for Difficult and Complicated Diseases, stated: "We hope to take this conference as an opportunity, based on the solid work already done by the Oncology Cooperation Committee, to further strengthen clinical collaboration and the inheritance of experience. This will allow the academic thoughts and clinical expertise of renowned senior experts in addressing complex tumors to be systematically passed down, and enable effective treatment protocols to be more quickly integrated into standardized clinical pathways, providing richer and more effective Traditional Chinese Medicine solutions for the world to address this 'difficult and complicated major condition.'"

Mr. Liu Guangyi, Standing Vice President of Beijing Research Association for Difficult and Complicated Diseases in Traditional Chinese Medicine, Delivers a Speech

Professor Li Zhong, Chairman of the Presidium of this conference, President of the World Federation of Chinese Medicine Societies' Specialized Committee on External Treatment Methods for Cancer, Chairman of the Tumor Collaboration Committee of the Beijing Research Society for Difficult and Complicated Diseases in Traditional Chinese Medicine, and Chairman of the TCM Oncology Branch of the Beijing Integrated Medicine Association, as well as the founder of the "Cancer State" therapy, stated in his speech: "This conference is not only a summary of twelve years of academic achievements in the field of external treatment methods for cancer within the society, but also an important exploration to promote the deep integration of traditional Chinese medicine (TCM) with modern technology and to move towards internationalization and standardization. In the face of major public health challenges in global cancer prevention and control, the multi-target and holistic regulation advantages of TCM in the entire cycle of cancer prevention, treatment, and rehabilitation have drawn significant attention. The integration of modern technologies such as artificial intelligence and big data will open up new dimensions for the modernization pathway of TCM. In the future, using this conference as a new starting point, we will continue to promote academic innovation and practical implementation in external treatment methods for TCM oncology, and work together with colleagues worldwide to advance high-quality development in the field of TCM oncology."

Chairman of the Presidium, Professor Li Zhong, Delivers a Speech

At the opening ceremony, the much-anticipated "Five Hundred Project of Traditional Chinese Medicine (TCM) Oncology" was officially announced. As a core initiative of this project, the "Hundred Experts, Hundred Lectures" program was jointly launched by the World Federation of Chinese Medicine Societies - Special Committee on External Treatment Methods in Oncology, the TCM Oncology Branch of Beijing Integrated Medicine Association, and the Oncology Cooperation Committee of Beijing TCM Difficult Disease Research Association. The program brings together a hundred experts in the field of TCM and Western medicine oncology from within and outside China, systematically creating a high-quality curriculum system for TCM oncology that covers multiple dimensions such as theoretical research, clinical practice, and technology promotion. This provides a comprehensive and in-depth learning and exchange platform for clinical doctors. Currently, all one hundred lectures have been recorded and will be promoted through a combination of online and offline methods. The conference also held a certificate-awarding ceremony for representatives of the "Hundred Experts, Hundred Lectures" expert group, marking the entry of the project into a substantive advancement phase.

"Five Hundred" Launch Ceremony and Certificate Awarding Ceremony

As the highlight of this academic conference, the academic exchange session meticulously planned five major academic forums: Famous Doctor Inheritance, External Treatment of Tumors Applications, Integrated Traditional Chinese and Western Medicine in Oncology, Clinical Practice, and Integrative Innovation. Eighteen authoritative experts delivered excellent thematic reports. Professor Rong Zhen from Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine presented "Reflections on Several Issues in Tumor Diagnosis and Treatment," Professor He Fule from Zhejiang University of Traditional Chinese Medicine presented "Inheritance and Innovation of the Virtual-Toxin Carcinogenesis Theory in Clinical Practice," Professor Zheng Xuezhi from Dongzhimen Hospital, Beijing University of Chinese Medicine, presented "Integrated Prevention and Treatment of Cancer with Chinese and Western Medicine – Application of 'Cancer State' Therapy in Triple-Negative Breast Cancer," Professor Wang Shaoxia, founder of the Center for External Treatment of Tumors at Henan Cancer Hospital, presented "Application of Traditional Chinese Medicine External Treatment Methods in the Prevention and Treatment of Digestive System Tumors," Professor Huang Xianbao from the Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine presented "Practical Experience of Thermosensitive Moxibustion in Promoting High-Quality Coexistence of Humans and Tumors," Professor Wang Hongwu from Dongzhimen Hospital, Beijing University of Chinese Medicine, presented "Integrative Treatment of Malignant Airway Tumors," Professor Cheng Zhiqiang from China-Japan Friendship Hospital presented "Treatment Strategies of Traditional Chinese Medicine for Adverse Reactions to Immunotherapy and Targeted Drugs," Professor Zhu Shijie from Wangjing Hospital, China Academy of Chinese Medical Sciences, presented "Case Analysis and Data Mining of Traditional Chinese Medicine in Treating Cancer-Related Fever," Academician Baofa Yu of the Russian Academy of Natural Sciences presented "Innovative Integration of Chinese and Western Medicine in Cancer Treatment: 27 Years of Exploration into Intratumoral Self-Nano Sustained-Release Cancer Therapy," Professor Xu Li from Nanjing University of Chinese Medicine presented "Profound Implications of Tumor Heterogeneity for Traditional Chinese Medicine Treatment," Professor Jiang Shizhong from the First Affiliated Hospital of Henan University of Chinese Medicine presented "Clinical Thinking and Strategy of Warming Yang, Dissipating Masses, and Detoxifying Method in Malignant Tumor Treatment," Professor Xu Shu from Beijing University of Chinese Medicine presented "Three Differentiations and Six Therapies for Nasopharyngeal Carcinoma," Professor Luo Anming from Xinzhou District Hospital of Traditional Chinese Medicine in Wuhan presented "From 'Cold Syncope Forming Accumulation' to 'Yin-Yang Repulsion': Deepening Understanding of Traditional Chinese Medicine Tumor Pathogenesis Theory and Its Implications for Integrated Chinese and Western Medicine Diagnosis and Treatment," Professor Gao Qilong from Henan Cancer Hospital presented "Symptom Control with Traditional Chinese Medicine Techniques in Palliative Care for Cancer," Professor Liang Shuang from Yinchuan Hospital of Traditional Chinese Medicine, Ningxia Medical University, presented "Advantages and Clinical Practice Cases of Traditional Chinese Medicine in Improving Radiotherapy and Chemotherapy Reactions," Professor Ren Yandong, Executive President of the Shenzhen Association of Senior Practitioners of Traditional Chinese Medicine, presented "Chronic Disease Management with Traditional Chinese Medicine and Practical Application of Clinical Prescriptions," Mr. Song Dayong, leader of the National Legacy Studio of Elderly Pharmacist Song Dayong, presented "Impact of Traditional Processing of Chinese Medicinal Herbs on Tumor Treatment Efficacy," and Ms. Liu Hongjia, a member of the Chronic Disease Management Committee of the Shenzhen Association of Senior Practitioners of Traditional Chinese Medicine, presented "Multimodal Diagnosis and Treatment of 'Cancer State' – Clinical Diagnosis, Treatment, and Practice of Three-Spectrum Integration." These reports covered core areas such as basic research, clinical techniques, and interdisciplinary innovation, presenting a high-quality academic feast.

Collection of Academic Sharing Experts

Professor Xu Li from Nanjing University of Chinese Medicine, Professor Jiang Shiqing from the First Affiliated Hospital of Henan University of Chinese Medicine, Professor Ma Chunzheng, Executive Vice President of Henan Hospital affiliated with Longhua Hospital of Shanghai University of Chinese Medicine, Professor Li Rending from the Affiliated Hospital of Shaanxi University of Chinese Medicine, Professor Rong Zhen from Shenzhen Traditional Chinese and Western Medicine Hospital, Professor Gu Honghui from Shenzhen Traditional Chinese Medicine Hospital, Professor Zheng Xuezhi from Dongzhimen Hospital of Beijing University of Chinese Medicine, Professor Wang Tongbiao from Shenzhen Integrated Traditional Chinese and Western Medicine Hospital, Professor Yang Zhenjiang from Shenzhen Traditional Chinese Medicine Hospital, and Professor Wang Yujia from Yinchuan Traditional Chinese Medicine Hospital affiliated with Ningxia Medical University respectively served as the conference chairs for five academic exchange sessions. They provided professional commentary on the academic presentations, further enhancing the effectiveness of the academic exchanges.

Collection of Academic Conference Chairs

In addition, the conference focused on the theme of "Digital Empowerment for Innovative Development of Traditional Chinese Medicine (TCM) in Oncology," and specially arranged the session "First Intelligent TCM Oncology Fusion Innovation Exchange." In the keynote speech, Professor Li Zhong's presentation titled "Thoughts on Digital Intelligence Technology Empowering the Development of TCM" highlighted a clinical and health management model based on "Dynamic Tongue Diagnosis AI" as a breakthrough. The presentation showcased the application value of this technology in intelligent tongue image recognition, health risk screening, and personalized health management. Through the vertical model of "Yufang Maiguan" in TCM oncology, it is possible to achieve full lifecycle health management encompassing prevention, screening, diagnosis, treatment, and rehabilitation, empowering patients' self-management and enabling precise diagnosis and treatment by doctors. He emphasized that true digital intelligence in TCM should be rooted in real clinical scenarios, guided by the core needs of doctors and patients, promoting standardization, personalization, and intelligent transformation in TCM diagnosis and treatment, ultimately realizing the vision of "making everyone their own health manager and enabling every doctor to become an expert." At this conference, the doctor's end of "Yufang Maiguan" was officially launched, marking the platform's achievement of a dual-end closed loop between patients and doctors. It will provide intelligent support such as auxiliary diagnosis and medical record management for clinical diagnosis and treatment, advancing TCM oncology towards standardization and intelligence.

Professor Li Zhong Keynote Speech

"Yufang Maiguan" Doctor End启动仪式

Ms. He Haifeng, Director of the Product Strategy Center of Xiangyu Medical Co., Ltd., delivered a keynote speech titled "Brain-Computer Interface+: Reshaping the New Landscape of Cancer Rehabilitation." She systematically explained the current practical bottlenecks in cancer rehabilitation: tumor patients experience restricted limb movement, cognitive decline, and heavy psychological burdens due to surgery, radiotherapy, and chemotherapy. Traditional rehabilitation methods often rely on active patient cooperation, which has limitations in precision and personalization. She emphasized that the core value of brain-computer interface technology lies in "direct communication with the brain," enabling rehabilitation interventions driven by "thought" through capturing and decoding neural signals. This allows the rehabilitation process to begin at the earliest stage when patients are unable to move voluntarily, truly achieving "full-cycle intervention."

Keynote Speech by Ms. He Haifeng, Director of the Product Strategy Center of Xiangyu Medical Co., Ltd.

At the expert exchange session of the "First Digital Intelligence and Traditional Chinese Medicine Oncology Integration and Innovation Exchange Conference," Li Zhong, President of the External Treatment Methods for Tumors Committee of the World Federation of Chinese Medicine Societies, Professor You Hailing from Beijing University of Chinese Medicine Shenzhen Hospital, Professor Ning Lianju from the Big Data and Business Model Innovation Research Center at Beijing University of Posts and Telecommunications, Fan Sikuo, a digital intelligence and traditional Chinese medicine expert, and He Haifeng, Director of the Product Strategy Center at Xiangyu Medical Co., Ltd., conducted in-depth discussions from multiple dimensions including clinical practice, data governance, technology research and development, hospital management, and industry promotion. They are committed to building a new paradigm for human-centered, digitally empowered traditional Chinese medicine oncology diagnosis and treatment, contributing Chinese wisdom and solutions to the global cause of cancer prevention and treatment.

The First Intelligent Medical Oncology Fusion Innovation Exchange Session

Reportedly, in order to gather the core academic strength in the field of Traditional Chinese Medicine (TCM) oncology, enhance cross-institutional collaboration, and jointly promote the high-quality development of TCM oncology, on December 6, the Professional Committee of External Therapies for Tumors of the World Federation of Chinese Medicine Societies, the TCM Oncology Branch of Beijing Integrated Medicine Association, and the Tumor Cooperation Committee of Beijing Research Association for Difficult and Complicated Diseases in TCM jointly convened an executive council meeting. Executive Deputy Secretary-General Ms. Yan Zheng reported on the overall progress and future plans of the three branches. She stated that under the leadership of President Li Zhong, the association has successfully hosted international academic annual conferences for twelve consecutive years, developed the "Yufang Mai Guan" intelligent TCM tongue diagnosis platform for tumors, established the "Cancer Status Studio" and the "Zhongyuan Multidisciplinary Tumor Consultation Platform," and organized nine sessions of public welfare activities for patient-doctor science popularization conferences... Achieving solid results in standardizing TCM tumor diagnosis and treatment, transforming academic achievements, and improving public health literacy, gradually building a "high-level TCM oncology academic community" that gathers top experts from home and abroad and integrates the strengths of both Chinese and Western medicine. At the meeting, the experts unanimously agreed that building a "high-level TCM oncology academic community" is a key measure to consolidate efforts and lead development, and provided valuable suggestions for future work directions. In his summary, President Li Zhong said: "This meeting marks a new step for the three branches in resource integration and collaborative innovation. In the future, we will continue to strengthen the leading role of the academic community, deepen the construction of the TCM tumor prevention and treatment system, and contribute more wisdom and strength to promoting the inheritance and innovation of TCM and serving the Healthy China strategy."

Scene of the Standing Council Meeting

The successful hosting of this academic conference is not only a vivid practice of inheritance and innovation in the field of traditional Chinese medicine (TCM) oncology, but also an important exploration of the integration of TCM and Western medicine, as well as digital intelligence technology and TCM. By gathering top industry resources, the conference has built a high-level platform for academic exchange and achievement transformation. It not only showcased the latest advances in external treatment methods of TCM for tumors, integrated prevention and treatment of TCM and Western medicine, and intelligent TCM tumor diagnosis and treatment, but also consolidated industry development consensus, injecting strong momentum into the high-quality development of the TCM oncology field. In the future, with the implementation and promotion of various academic achievements and the widespread application of innovative technologies, TCM will play a greater role in the field of cancer prevention and treatment, bringing more hope to cancer patients.